BrightHeart secures CE mark for AI-powered prenatal ultrasound platform

New Products

Summary

BrightHeart has secured CE mark approval for its AI-powered prenatal ultrasound platform, B-Right AI, expanding its reach into Europe after earlier FDA clearance in the US. The platform standardizes prenatal ultrasound workflows and helps clinicians interpret scans, with the goal of improving detection of fetal heart defects and congenital anomalies. BrightHeart says the tool can support less experienced staff and improve consistency in environments facing workforce shortages. The article also notes recent funding, upcoming European rollout plans, and integration with GE Healthcare’s Voluson ultrasound systems.

Classifications

industries
HealthTech
applications
Data Management

AskAI Classifications

Labels
Healthcare Software SaaS AI and Machine Learning Software

Linked Companies

Diagnoly
up to $1M
BrightHeart
$1M to $5M